139 related articles for article (PubMed ID: 16828180)
1. Late gadolinium-enhanced cardiovascular magnetic resonance identifies patients with standardized definition of ischemic cardiomyopathy: a single centre experience.
Soriano CJ; Ridocci F; Estornell J; Pérez-Boscá JL; Pomar F; Trigo A; Planas A; Nadal M; Jacas V; Martinez V; Paya R
Int J Cardiol; 2007 Mar; 116(2):167-73. PubMed ID: 16828180
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance.
Soriano CJ; Ridocci F; Estornell J; Jimenez J; Martinez V; De Velasco JA
J Am Coll Cardiol; 2005 Mar; 45(5):743-8. PubMed ID: 15734620
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.
McCrohon JA; Moon JC; Prasad SK; McKenna WJ; Lorenz CH; Coats AJ; Pennell DJ
Circulation; 2003 Jul; 108(1):54-9. PubMed ID: 12821550
[TBL] [Abstract][Full Text] [Related]
4. Late gadolinium enhancement-cardiovascular magnetic resonance identifies coronary artery disease as the aetiology of left ventricular dysfunction in acute new-onset congestive heart failure.
Valle-Muñoz A; Estornell-Erill J; Soriano-Navarro CJ; Nadal-Barange M; Martinez-Alzamora N; Pomar-Domingo F; Corbí-Pascual M; Payá-Serrano R; Ridocci-Soriano F
Eur J Echocardiogr; 2009 Dec; 10(8):968-74. PubMed ID: 19755468
[TBL] [Abstract][Full Text] [Related]
5. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
[TBL] [Abstract][Full Text] [Related]
6. Identification of the ischemic etiology of heart failure by cardiovascular magnetic resonance imaging: diagnostic accuracy of late gadolinium enhancement.
Casolo G; Minneci S; Manta R; Sulla A; Del Meglio J; Rega L; Gensini G
Am Heart J; 2006 Jan; 151(1):101-8. PubMed ID: 16368300
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
[TBL] [Abstract][Full Text] [Related]
8. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease.
Kwong RY; Chan AK; Brown KA; Chan CW; Reynolds HG; Tsang S; Davis RB
Circulation; 2006 Jun; 113(23):2733-43. PubMed ID: 16754804
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction.
Di Bella G; Pingitore A; Piaggi P; Pizzino F; Barison A; Terrizzi A; d'angelo M; Todiere G; Quattrocchi S; Carerj S; Emdin M; Aquaro GD
Int J Cardiol; 2016 Dec; 224():337-342. PubMed ID: 27668708
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
11. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis.
Bondarenko O; Beek AM; Nijveldt R; McCann GP; van Dockum WG; Hofman MB; Twisk JW; Visser CA; van Rossum AC
J Cardiovasc Magn Reson; 2007; 9(5):815-21. PubMed ID: 17891620
[TBL] [Abstract][Full Text] [Related]
12. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
Moon JC; Mogensen J; Elliott PM; Smith GC; Elkington AG; Prasad SK; Pennell DJ; McKenna WJ
Heart; 2005 Aug; 91(8):1036-40. PubMed ID: 16020591
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy.
Alter P; Rupp H; Adams P; Stoll F; Figiel JH; Klose KJ; Rominger MB; Maisch B
Eur J Heart Fail; 2011 Sep; 13(9):937-44. PubMed ID: 21803756
[TBL] [Abstract][Full Text] [Related]
14. Diffuse late gadolinium enhancement by cardiovascular magnetic resonance predicts significant intraventricular systolic dyssynchrony in patients with non-ischemic dilated cardiomyopathy.
Tigen K; Karaahmet T; Kirma C; Dundar C; Pala S; Isiklar I; Cevik C; Kilicgedik A; Basaran Y
J Am Soc Echocardiogr; 2010 Apr; 23(4):416-22. PubMed ID: 20149594
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of cardiac magnetic resonance imaging.
Pilz G; Heer T; Harrer E; Ali E; Hoefling B
Minerva Cardioangiol; 2009 Jun; 57(3):299-313. PubMed ID: 19513011
[TBL] [Abstract][Full Text] [Related]
16. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
[TBL] [Abstract][Full Text] [Related]
17. Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with q waves in hypertrophic cardiomyopathy.
Papavassiliu T; Flüchter S; Haghi D; Süselbeck T; Wolpert C; Dinter D; Kühl H; Borggrefe M
J Cardiovasc Magn Reson; 2007; 9(3):595-603. PubMed ID: 17365241
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, pattern, and functional impact of late gadolinium enhancement in left ventricular hypertrophy due to aortic valve stenosis.
Nassenstein K; Bruder O; Breuckmann F; Erbel R; Barkhausen J; Schlosser T
Rofo; 2009 May; 181(5):472-6. PubMed ID: 19241322
[TBL] [Abstract][Full Text] [Related]
19. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.
Yan AT; Gibson CM; Larose E; Anavekar NS; Tsang S; Solomon SD; Reynolds G; Kwong RY
J Cardiovasc Magn Reson; 2006; 8(6):831-7. PubMed ID: 17060106
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.
Bello D; Shah DJ; Farah GM; Di Luzio S; Parker M; Johnson MR; Cotts WG; Klocke FJ; Bonow RO; Judd RM; Gheorghiade M; Kim RJ
Circulation; 2003 Oct; 108(16):1945-53. PubMed ID: 14557364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
